Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2022	Jun. 30, 2022
Current assets
Cash and cash equivalents	$ 278	$ 183
Receivables, net	612	681
Inventories, net	755	755
Prepaid expenses and other current assets	118	106
Total current assets	1,763	1,725
Property, plant and equipment, net of accumulated depreciation and amortization of $2,575 and $2,530, respectively	1,322	1,334
Operating lease right-of-use assets	336	342
Goodwill	1,546	1,558
Trademarks, net	685	687
Other intangible assets, net	190	197
Other assets	311	315
Total assets	6,153	6,158
Current liabilities
Notes and loans payable	348	237
Current operating lease liabilities	78	78
Accounts payable and accrued liabilities	1,584	1,469
Total current liabilities	2,010	1,784
Long-term debt	2,475	2,474
Long-term operating lease liabilities	308	314
Other liabilities	805	791
Deferred income taxes	59	66
Total liabilities	5,657	5,429
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September 30, 2022 and June 30, 2022; and 123,355,986 and 123,152,132 shares outstanding as of September 30, 2022 and June 30, 2022, respectively	131	131
Additional paid-in capital	1,193	1,202
Retained earnings	832	1,048
Treasury stock, at cost: 7,385,475 and 7,589,329 shares as of September 30, 2022 and June 30, 2022, respectively	(1,315)	(1,346)
Accumulated other comprehensive net (loss) income	(515)	(479)
Total Clorox stockholders’ equity	326	556
Noncontrolling interests	170	173
Total stockholders’ equity	496	729
Total liabilities and stockholders’ equity	$ 6,153	$ 6,158